A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

Clinical trial NCT04316364 · RECRUITING

Trial details

NCT number: NCT04316364
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer

Start date: 2020-07-14
Primary completion: 2023-04-15
Enrollment: 537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.